Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 4:14 pm Sale | 2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS | CANTOR FITZGERALD SECURITIES | 0 0.000% | -1,602,204 (Position Closed) | Filing History |
| 2024-02-09 10:26 am Sale | 2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Polar Asset Management Partners Inc. | 0 0.000% | -1,189,211 (Position Closed) | Filing History |
| 2024-02-07 2:00 pm Sale | 2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Saba Capital Management, L.P. | 0 0.000% | -1,791,845 (Position Closed) | Filing History |
| 2024-01-19 3:46 pm Sale | 2023-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Highbridge Capital Management, LLC | 0 0.000% | -1,482,836 (Position Closed) | Filing History |
| 2023-06-12 9:44 pm Unchanged | 2023-06-02 | 13D | BioPlus Acquisition Corp. BIOS | BioPlus Sponsor LLC | 6,630,000 34.200% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:38 pm Purchase | 2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS | CANTOR FITZGERALD SECURITIES | 1,602,204 6.800% | 350,375 (+27.99%) | Filing History |
| 2023-02-14 06:13 am Purchase | 2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Saba Capital Management, L.P. | 1,791,845 7.600% | 1,791,845 (New Position) | Filing History |
| 2023-02-09 3:01 pm Purchase | 2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Polar Asset Management Partners Inc. | 1,189,211 5.050% | 1,189,211 (New Position) | Filing History |
| 2023-02-02 10:10 am Purchase | 2022-12-31 | 13G | BioPlus Acquisition Corp. BIOS | Highbridge Capital Management, LLC | 1,482,836 6.290% | 1,482,836 (New Position) | Filing History |
| 2022-11-02 5:25 pm Purchase | 2022-10-27 | 13G | BioPlus Acquisition Corp. BIOS | CANTOR FITZGERALD SECURITIES | 1,251,829 5.310% | 1,251,829 (New Position) | Filing History |
| 2022-02-14 06:59 am Purchase | 2021-12-31 | 13G | BioPlus Acquisition Corp. BIOSU | Saba Capital Management, L.P. | 1,500,000 6.400% | 200,000 (+15.38%) | Filing History |
| 2022-02-09 2:14 pm Sale | 2021-12-31 | 13G | BioPlus Acquisition Corp. BIOSU | MMCAP International Inc. SPC | 650,000 3.160% | -350,000 (-35.00%) | Filing History |
| 2021-12-17 4:46 pm Purchase | 2021-12-07 | 13D | BioPlus Acquisition Corp. BIOS | BioPlus Sponsor LLC | 6,630,000 22.400% | 6,630,000 (New Position) | Filing History |
| 2021-12-13 2:43 pm Purchase | 2021-12-03 | 13G | BioPlus Acquisition Corp. BIOSU | Saba Capital Management, L.P. | 1,300,000 5.500% | 1,300,000 (New Position) | Filing History |
| 2021-12-10 5:19 pm Purchase | 2021-12-06 | 13G | BioPlus Acquisition Corp. BIOSU | MMCAP International Inc. SPC | 1,000,000 5.000% | 1,000,000 (New Position) | Filing History |
| 2021-12-10 08:40 am Purchase | 2021-12-02 | 13G | BioPlus Acquisition Corp. BIOSU | Highbridge Capital Management, LLC | 1,051,735 4.460% | 1,051,735 (New Position) | Filing History |